Nautilus Biotechnology Inc
Follow $NAUT
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $NAUT by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is NAUT moving today?
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
NAUT overview
Related filings and maps
Congress activity in NAUT
No receipt-qualified Congressional disclosure is present for NAUT in the cached public ledger.
NAUT contract awards, year to date.
Public federal awards linked to this ticker.
NAUT lobbying filings, year to date.
Registered lobbying filings matched to Nautilus Biotechnology Inc.